Home / Atorvastatin / Italy
IT ATC C10AA05 · updated 2 Nov 2026
Atorvastatin shortage in Italy
Is there an Atorvastatin shortage in Italy?
Yes. As of 2 Nov 2026, 12 Atorvastatin products are reported short in Italy, the first since 15 Jun 2024. The company estimate for the return is 31 Mar 2027 (latest 30 Apr 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | TORASTIN | I.B.N. SAVIO S.R.L | 15 Jun 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | TORASTIN | I.B.N. SAVIO S.R.L | 15 Jun 2024 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | TORASTIN | I.B.N. SAVIO S.R.L | 13 Sep 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | ATORVASTATINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 6 Mar 2026 | not given | Increased demand Elevata richiesta |
| IT | ATORVASTATINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 20 Mar 2026 | not given | Increased demand Elevata richiesta |
| IT | ATORVASTATINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 13 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | ATORVASTATINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 20 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | ATORVASTATINA VIATRIS | VIATRIS PHARMA S.R.L. | 26 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | ATORVASTATINA PENSA PHARMA | TOWA PHARMACEUTICAL S.P.A. | 1 Nov 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | ATORVASTATINA VIATRIS anticipated | VIATRIS PHARMA S.R.L. | 10 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | ATORVASTATINA VIATRIS anticipated | VIATRIS PHARMA S.R.L. | 25 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | ATORVASTATINA PENSA PHARMA anticipated | TOWA PHARMACEUTICAL S.P.A. | 1 Jan 2027 | 30 Apr 2027 | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.